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Summary
The initiation of callus cultures and in vitro cultivation of plant cells, 
even in large bioreactors, has become a routine task. Despite the fact, 
that permanent cell and organ cultures can produce a whole range 
of small natural compounds (SNAPs) used in medicine, only a few 
could be produced at commercial scale. However, plant cell cultures 
provide very useful systems to study the biosynthetic pathways 
leading to SNAPs at the enzyme and gene level. They turned out to 
be ‘a pot of gold’ for those chasing the enzymes and genes involved in 
natural product formation. The use of genetically modified yeast and 
bacteria for the production of SNAPs is an emerging technique that 
will take research into the coming decades. This review contemplates 
and revisits developments in the field of using plant cell and tissue 
culture as tools to elucidate SNAP formation and means to produce 
bioactive plant natural products over the past 40 years alongside my 
own work.
Keywords: Secondary metabolism, Specialized metabolism, Cell 
suspension culture, Bioreactor, Elicitation, Biochemical pathways, 
Natural products
Introduction
A multitude of small natural products (SNAPs), such as alkaloids, 
small peptides, isoprenoids, phenolics, and polyketides generated by 
plants are used as pigments, food additives or pharmaceuticals. Some 
of them are bioactive in an ecological or co-evolutionary sense. In 
an average plant about 90% of the individual products formed can 
be characterized as SNAPs (Firn, 2010) although some are only 
produced in trace amounts. 
As early as the 1970s my interest in the biochemistry, physiology, 
chemistry, and analysis of SNAPs was sparked and still I regard each 
discipline as equally important when dealing with SNAP formation. 
At that time SNAPs were sometimes regarded as ’flotsam and jetsam 
on the metabolic beach‘ (Haslam, 1986). The model of chemical 
co-evolution eventually brought them into focus (Hartmann, 1996) 
and the vast structural diversity kindled much enthusiasm and 
attracted many researchers. Jones and Firn (1991) introduced the 
screening hypothesis in order to explain the existence of hundreds 
of thousands of individual SNAPs. Their hypothesis is based on the 
assumption that organisms making SNAPs face the same challenges 
as pharmaceutical companies trying to find new drugs. Only recently, 
noda-Garcia et al. (2018) have offered an integrative metabolite-
enzyme co-evolution hypothesis proposing that metabolite pools 
change alongside the appearance of newly evolved enzymes. If an 
emerging SNAP provides a selective advantage for its producer, 
enzymes will be recruited or shaped resulting in improved synthesis. 
Any of these hypotheses try to explain the occurrence of the 
multiplicity of SNAPs. These hypotheses rather complement than 
contradict each other and may even be merged.
In the 1970s reports on the biosynthesis of SNAPs were still limited. 
How did we study SNAP biogenesis in these days? Beadle and 
tatum (1941) used Neurospora crassa as a model organism to 
elucidate biochemical pathways. They established that individual 
gene mutations were responsible for single metabolic steps (‘one gene-
one enzyme’ hypothesis) by constructing mutant strains requiring 
specific amino acids or vitamins for their survival. This approach, 
however, could not be successfully employed in elucidating the 
pathways leading to SNAPs. They are not necessary for the survival 
of the producing cell, lethal mutants could not be generated and their 
deficiencies then repaired by adding appropriate precursors. The 
only change in phenotype that could easily be observed was pig- 
ment formation (see Selection and characterization of biochemical 
mutants). Many of the pathways shown in the textbooks were based 
on chemical plausibility or studies using radiolabeled compounds 
assumed to be precursors in a particular pathway. Experiments were 
usually carried out with whole plants or excised plant organs. One 
particular booklet (Bu’Lock, 1965), translated into German and also 
slightly edited by Wolfgang Barz and Hans Grisebach (Bu’Lock, 
1972), was sufficient to convince me that the field ‘biosynthesis of 
natural products’ is large enough to nurture generations of scientists.
Traditionally SNAPs are isolated from intact plants since chemical 
synthesis proved to be complicated and expensive. Production of 
SNAPs by plant cell cultures could provide an alternative source 
of SNAPs. Articles reviewing this idea generally begin with the 
statement that hundreds of plants have been used to establish cell 
cultures. Among these plants are many endangered species and a lot 
of plants containing compounds with, e.g., anti-cancer, neuroprotec- 
tive or anti-malarial activities. Most of the reviews repeat the 
following statements like a mantra: as an alternative way to produce 
SNAPS, cell and tissue culture have the advantages that (1) fields 
can be freed up for growing crops instead, that (2) plant cell culture 
systems are not affected by weather and season changes and that 
(3) their metabolism can be manipulated to maximize production. 
One may challenge all of these statements and find arguments 
contradicting them. For example, in Germany medicinal and aromatic 
plants are cultivated on only 13,000 ha (IvA, 2019) whereas cereals 
occupy about 6,000,000 ha (aGraVis, 2019). These figures warrant 
criticism against the first argument. The overwhelming amount of 
literature on plant cell cultures and their use in SNAP formation 
made it impossible to write a non-biased review covering the 
developments over the past 40 years. A literature search conducted 
on the Google Scholar Website using the search terms “natural 
products” and “plant cell suspension” and covering the years 2015 - 
2019 yielded 386 hits, among them 52 reviews or book chapters (e.g., 
dias et al., 2016; ocHoa-Villarreal et al., 2016; Yue et al., 2016). 
A recent meta-analysis study came to the conclusion that plant cell 
technology is the best strategy for production of natural-based drugs 
(daVoodi et al., 2019). Contemplating on this astonishing statement 
and the plentitude of quite recent reviews I here tried to put my own 
experiences in the field in a methodological and historical context 
and give my very own assessment of the state-of-the-art (Fig. 1).
I took the book entitled ‘Plant Tissue Culture and Its Biotechnologi-
cal Application’ (Barz et al., 1977) as my personal starting point. 
The proceedings, edited by Wolfgang Barz (Münster), Ernst Rein-
hard (Tübingen), and Meinhart Zenk (München), documented the 
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state-of-the-art in the field at the time. Well-reputed scientists from 
all over the world shared their experiences and the titles of their con-
tributions could still be used to structure a review article today. In 
these proceedings alFermann et al. (1977) put forward the results 
of Ernst Reinhards’s group in Tübingen in a contribution entitled 
’Biotransformation of Cardiac Glycosides by Plant Cell Cultures’ 
and I was lucky enough to get a postgraduate position in this particu-
lar group in 1983 where I got the chance to combine in my research 
analytical, plant physiological, biochemical and biotechnological as-
pects of plant cell culture (see Growth of plant cells in bioreactors). 
Plant cell cultures are nowadays also considered to produce recom-
binant proteins, such as antibodies. However, this issue will not be 
touched here and the reader is referred to other reviews dealing with 
various aspects of protein production by suspension-cultured plant 
cells (FisHer et al., 1999; HuanG and mcdonald, 2009; tekoaH 
et al., 2015).
Initiation of plant cell cultures
In 1934, WHite and GautHeret independently demonstrated that 
plant cells and tissues can be grown and propagated for long periods 
of time in complex media. By including indole-3-acetic acid and 
vitamins in his media, GautHeret (1934) extended the culture period 
of callus to 18 months by including indole-3-acetic acid and vitamins 
in his media and he was able to subculture the tissue aseptically. 
routien and nickell (1956) described the submerged cultivation of 
tissues of several plant species and were granted the first patent for the 
cultivation of plant cells in vitro. Today, the initiation of plant cell and 
tissue cultures and cultivation of plant cells and tissues in vitro has 
become routine. Cell behavior can be triggered with phytohormones 
and even regeneration of intact plants became possible. A number of 
chemical factors like media components, phytohormones and pH as 
well as physical factors like light, aeration and temperature, which 
can affect plant cell growth in vitro have been investigated. Several 
textbooks, proceedings and lab manuals have been published over 
the past four decades to cover the topic more comprehensively than 
possible here (reinert and Yeoman, 1982; allen, 1991; GamBorG 
and PHiliPPs, 1995; coleman et al., 2003; loYola-VarGas and 
ocHoa-aleJo, 2018). Under certain conditions plant cells can 
grow as dedifferentiated callus masses. Culture media usually in- 
clude salts of inorganic macro-nutrients (N, P, S, K, Na, Ca, Mg) 
and micro-nutrients (I, Ni, Fe, Cu, B, Mn, Co) as well as vitamins 
and an appropriate carbohydrate source. The most common media 
for plant cell culture are those devised by murasHiGe and skooG 
(1962), GamBorG et al. (1968), scHenk and HildeBrandt (1972), 
and WHite (1934). Under certain conditions plant cells can grow as 
de-differentiated callus masses. After several medium changes these 
cell masses can be used to study various aspects of SNAP formation 
and eventually plant cell culture turned out to be an excellent system 
to understand and manipulate SNAP formation. Application of 
precursors or inhibitors is simple and analysis is facilitated by the 
fact that bulk compounds, such as phenolics or chlorophyll are not as 
abundant as, for example, in plant leaves. Long-distance transport does 
not happen in plant cell culture, an obvious advantage for studying 
SNAP metabolism. In intact plants precursors can be transported, 
sequestered and/or modified in various ways prior to reaching the 
site of SNAP biosynthesis. Precursors may even be degraded to very 
small molecules, such as acetate, which in turn can be used ‘second 
hand’ for SNAP formation. For example, the discovery of the non-
mevalonic acid terpenoid pathway (licHtentHaler et al., 1997) 
supported the view that studies with radio-labeled precursors can 
lead to ambiguous conclusions. This and other examples demonstrate 
that even ‘trodden’ pathways like those depicted in generations of 
textbooks, do need confirmation by using modern techniques (see 
Chasing enzymes of SNAP formation in plant cell cultures). Plant 
cell cultures are an appropriate tool to do so provided they express 
the pathway to be examined.
SNAP formation in callus cultures
Extensive lists of plant cell cultures accumulating bioactive 
SNAPs of most of the biosynthetic classes known were compiled 
(mulaBaGal and tsaY, 2004; karuPPusamY, 2009). Many of 
the reports cited used callus cultures, which provide a reliable 
and easily accessible material for conducting biosynthetic studies. 
Callus cultures of Portulaca grandiflora Hook. were the first cell 
cultures to catch my interest. They produce betalains and depending 
on their biosynthetic capacity they accumulate red and yellow 
pigments possessing a betalamic acid moiety. Betalamic acid is 
derived from L-tyrosin needing a 4,5-dioxygenase, which has been 
isolated from P. grandiflora (cHristinet et al., 2004). L-tyrosine is 
also a precursor of Cyclo-DOPA and the conjugation of betalamic 
acid with cyclo-DOPA yields betanidine. We found that betanidine 
biosynthesis is favored in the dark and that several catecholamines, 
including adrenaline, also accumulate in darkness. Methyldopa, a 
drug developed for the treatment of high blood pressure, inhibited 
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Fig. 1:  Strategies for the alternative production of natural products (SNAPs). 
Special emphasis is only put on plant cell suspension cultures. The 
latest results gained from the cultivation of genetically transformed 
roots are not taken into account. The use of microorganisms, in-
cluding microalgae, in the production of plant-borne SNAPs is not 
addressed in a comprehensive way here. Neither are methods for 
product isolation and release. Other products, like proteins, are not 
addressed in this review. The areas not reviewed in detail are shown 
in grey. Issues related to large-scale culture and commercialization 
are shown in blue. Methods using plant cell suspension cultures for 
pathway elucidation are shown in red. The black arrow indicates 
the path from a target product to an industrial process using plant 
cell suspension cultures. The arrow also defines the structure of this 
review.
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catecholamine biosynthesis in P. grandiflora callus (endress et al., 
1984). Some questions began to puzzle me: (1) Do plants somehow 
respond to the mammalian stress hormone adrenaline? (2) Could it be 
a ‘secondary’ metabolite in plants but a ‘primary’ one in humans? (3) 
Is the metabolism associated with its formation ‘secondary’? Much 
later, Firn and Jones (2009) stressed that the same biochemical 
rules apply for all pathways, albeit to a different extent because 
they operate under different evolutionary constraints. There is no 
theoretical basis for separating metabolisms into ‘primary’ and 
‘secondary’ and I decided to avoid these terms where ever possible. 
Actually, only a few basic metabolic principles provide access to the 
majority of SNAPs: (1) starting from biogenic amines Mannich-type 
reactions lead to a variety of alkaloids (‘alkaloid pathways’), (2) the 
isopentenyl-diphosphate/dimethyl allyl diphosphate system provides 
building units for a large number of terpenoid skeletons (‘terpenoid 
pathways’), (3) phenolic acids derived from phenylalanine and 
tyrosine provide building blocks for a large number of phenolics 
(‘phenylpropanoid pathway’), (4) malonyl-CoA derived from acetyl-
CoA provides a universal and sequential C2-group donor used in the 
formation of a plentitude of polyketides (‘polyketide pathway’). (5) 
Small peptides can be produced via the processing of ribosomally 
produced precursors or with the help of nonribosomal peptide syn- 
thetases (BarBer et al., 2013).
The rich diversity of SNAPs found arises from modifications by 
only a limited number of chemical substitution types, such as 
hydroxylation, glycosylation, acylation, prenylation, and methylation. 
The formation of members of all the biogenetic groups mentioned 
have been investigated in plant cell cultures (see Chasing enzymes of 
SNAP formation in plant cell cultures).
Selection and characterization of biochemical mutants
Callus can be grown for months and even years. It is, however, a quite 
heterogeneous population of cells. Small clumps or aggregates can 
be picked from these cell masses to develop virtually homogeneous 
clones of fast growing viable cell cultures. Several screening and 
selection protocols have been developed (WidHolm, 1977; Berlin and 
sasse, 1985) and are still valid today. Elite cell lines can be obtained 
by selection following various strategies including macroscopical, 
microscopical and chemical inspection. Cell-aggregates or proto- 
plasts can be used as the starting material for selection (dix, 1990; 
kreis et al., 1992). variation can be enhanced employing induced 
physical or chemical mutagenesis (aHlooWalia et al., 2001; donini 
and sonnino, 1998). Selection can be achieved easily if the product 
of interest is a pigment. For example, anthocyanin-rich Euphorbia 
milii Des Moul. cells and cell clusters were selected and a cell strain 
was established producing 7 times as many anthocyanins as the 
initial cell culture (Yamamoto et al., 1982). Screening and selecting 
high-producing cell lines was not always successful and ‘recalcitrant’ 
cell cultures were the rule rather than the exception (kreis, 2003). 
Cell cultures of Papaver somniferum L., for instance do not produce 
quantities of morphinanes worth considering. Low or no apparent 
productivity of alkaloids in plant cell cultures was explained by 
insufficient cell differentiation (FarroW et al., 2012). This is sup-
ported by the fact, that non-producing plant cells may recover 
their biosynthetic capacity during morphogenesis. For example, in 
a Duboisia leichhardtii (F. Muell.) F. Muell. callus scopolamine 
production and accumulation was restored after root induction, but 
not after shoot induction (Yamada and endo, 1984). Root cultures, 
by the way, have also turned out to be suitable systems for producing 
SNAPs and for studying SNAP formation (oksman-caldenteY 
and arroo, 2000; sriVastaVa and sriVastaVa, 2007; Yue et al., 
2016) but this topic will not be reviewed here.
Plant tissues, when cultured in vitro, show genetic instability even 
without mutagenic treatment (staFFord, 1991). Cells can become 
habituated and ultimately exhibit hormone-autotroph callus growth 
which may explain the loss of regeneration potential after a pro- 
longed callus phase. For example, in callus of Digitalis mariana 
ssp. heywoodi (P. Silva & M. Silva) Hinz morphogenesis could still 
be induced after 24 months but not after 32 months. Cardenolide 
production was impaired in plants regenerated after several months 
of cultivation as callus (kreis et al., 2014). The variations occurring 
in plants regenerated from tissue culture or in permanent plant cell 
culture were termed ‘somaclonal variation‘ (larkin and scoWcroFt, 
1981), which will also occur in permanent plant cell culture. The 
‘apparent’ stability (meta-stability) of a plant cell culture ‘strain’ 
may be the effect of a strict subculture regime (ulBricH et al., 1985; 
FoWler, 1988) rather than the result of the clonal origin of the cells. 
The loss in productivity reported for many plant cell suspension 
cultures might be caused by rapidly dividing cells overgrowing 
the SNAP accumulating cells (staFFord, 1991). This phenomenon 
may constitute a problem for the establishment of a commercially 
viable plant cell culture process (see Commercialization of plant cell 
culture processes).
SNAP production using plant cell suspension cultures
Callus culture is not well suited as a method to commercially 
produce SNAPs. It cannot be used for the large-scale production of 
secondary metabolites because of slow growth rates and the lack of 
suitable bioreactor systems for their cultivation. However, calluses 
might disintegrate into small cell aggregates when submerged in 
liquid media yielding cell suspension cultures. Actually, most of the 
physiological and biochemical experiments designed for elucidating 
metabolic pathways have been carried out with suspension-cultured 
cells. The cells are kept in flasks on appropriate shakers to allow for 
aeration under various light-dark regimes. Reports on the production 
of SNAPS by plant cell cultures generally used small tissue samples 
grown in standard shake flasks allowing for easy sampling and 
additions to the suspensions. Growth curves are usually determined 
during process optimization. For this purpose, we introduced a 
simple, sample-free method to allow for rapid estimation of cell 
growth in Erlenmeyer flasks (Blom et al., 1992). The method proved 
to be very suitable to determine the increase of cell mass during 
each phase of the growth cycle and it is still used in our laboratory 
today.
Because metabolic activity is a function of the surface of an organism, 
growth and production rates of plant cell aggregates are much lower 
than those of microbial cells. In microbes secondary metabolite 
production is not necessarily associated with biomass production. 
Products are generally released into the bathing medium, production 
rates are high and production phases are short. The growth of plant 
cell cultures is quite slow, metabolite production is low and the 
products are usually stored in the cells (scraGG, 1995). For example, 
rosmarinic acid accumulates to 36% DW in cultured cells of Salvia 
officinalis L. (HiPPolYte et al., 1992), and berberine (koBaYasHi 
et al., 1988) or its derivative jatrorrhizine (BreulinG et al., 1985) 
can reach about 10% of the cells’ dry mass. Although the idea of 
using plant cell cultures for the production of SNAPs is reasonable 
and even hyped in the 1980s and 1990s, tables of successes are still 
quite short and should be regarded with caution as far as productivity 
claims are concerned (see Commercialization of plant cell culture 
processes). The list of plant cell cultures not producing the compounds 
of interest in amounts large enough to consider commercialization is 
much longer (kreis, 2007).
Elicitation of SNAP formation in plant cell cultures
Though all approaches to produce morphinanes in plant cell cultures 
so far have failed (see Selection and characterization of biochemical 
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mutants), compounds sharing the same precursors and intermediates 
as the morphinanes, such as benzophenanthridines, can accumulate 
in rather large amounts. It was demonstrated that the production of 
sanguinarine was even enhanced by adding preparations from fungal 
mycelia (eilert and constaBel, 1986) and many studies have 
shown, that SNAP production can be provoked by exposing cultured 
plant cells to fungal cell wall fragments (Barz, 1988; Park et al., 
1992; GundlacH et al., 1992). Preparations like these belong to the 
so-called ‘elictors’, exogenous molecules inducing physiological 
abnormalities that are often associated with plant pests. A broader 
definition of them includes exogenous and endogenous elicitors, 
as well as compounds released from plants in direct response to 
the pathogen. The label ’chemical elicitors‘ is now even used for 
substances like methyl jasmonate, methyl salicylate or benzoic acid, 
which are plant hormones and not elicitors in the original sense 
(Patel and krisHnamurtHY, 2013). For example, methyl jasmonate 
’elicitation‘ induced paclitaxel and related taxane production in 
Taxus cells (taBata, 2004; see Commercialization of plant cell cul- 
ture processes). The elicitor approach was not successful in all cases: 
morphinane biosynthesis, for example, could not be elicited as yet. 
Anyway, the application of elicitors (in the broader sense) has been 
considered as one of the most effective methods to improve the 
synthesis of SNAPs in plant cell cultures and elicitors can also be 
used to increase yield in field-grown plants (Baenas et al., 2014) 
demonstrating the impact of basic research conducted with plant cell 
cultures.
Biotransformation of SNAPs by plant cell cultures
Suspension-cultured cells can be used in so-called biotransformation 
processes. Biotransformation studies have been carried out with a 
view to (1) produce new chemicals, (2) produce known chemicals 
more economically, (3) investigate the metabolic fate of xenobiotics, 
and (4) elucidate metabolic pathways (reinHard and alFermann, 
1980; suGa and Hirata, 1990; stePan-sarkissian, 1991; Giri et al., 
2001). For example, none of the cell cultures investigated so far was 
able to produce scopolamine, a drug used in urinary incontinence and 
motion sickness, but the ultimate biosynthetic step, the conversion of 
hyoscyamine into scopolamine was realized in transgenic tobacco 
cell cultures (moYano et al., 2007). In one of our own more recent 
biotransformation studies cell suspension cultures of Digitalis lanata 
Erh. were fed with 21-O-acetyl-deoxycorticosterone and three new 
pregnane compounds were formed and their structures elucidated 
(type (1) approach; Pádua et al., 2012). In a type (2) approach, the 
commercially unavailable glucoevatromonoside, a natural carde- 
nolide inducing cancer type-specific cell death (scHneider et al., 
2018), was produced in D. lanata cell cultures (munkert et al., 
2017).
Already in the 1970s D. lanata cells cultivated in vitro were shown 
to convert digitoxin derivatives into digoxin derivatives (reinHard 
and alFermann, 1980). From this line of research a cell culture 
process has emerged where viable amounts of β-methyldigoxin are 
generated from β-methyldigitoxin, a semi-synthetic cardenolide with 
almost no side reactions. The β-methyldigoxin process was suc- 
cessfully scaled up to a volume of 200 L (alFermann et al., 1983; 
reinHard et al., 1989). 
At that stage the reason why digitoxin could not be used to estab- 
lish a putative digoxin process was unclear. Storage, transport and 
sequestration had not be considered to understand the cellular 
organization of the processes involved in cardenolide biotrans- 
formation. The vacuole was assumed to be a storage site for 
cardenolides but it could not be explained why some of the bio- 
transformation products were released into the bathing medium 
while others remained in the cells. Eventually, procedures to isolate 
intact vacuoles from plant cells cultivated in vitro became available 
and were used to investigate SNAP formation and storage (deus-
neumann and zenk, 1984; kreis and reinHard, 1985; mende 
and Wink, 1987; HoPP and seitz, 1987). After feeding digitoxin 
to suspension-cultured D. lanata cell we were able to demonstrate 
that only cardenolides possessing a terminal glucose moiety were 
stored in the vacuole. Moreover, we found that cardenolides without 
a terminal glucose enter the cells by simple diffusion, whereas 
those containing the glucose tag (termed ‘primary glycosides‘) are 
taken up actively (kreis and reinHard, 1987). Once accumulated, 
the primary glycosides were retained by the cells even if cyanide 
was added to the cell suspensions indicating that no energy was 
required to keep the primary glycosides stored. Of course, the 
enzymes involved in cardenolide biosynthesis had to be identified 
and characterized (see Chasing enzymes of SNAP formation in plant 
cell cultures). Finally, a model featuring the mechanisms involved in 
cardenolide biotransformation and storage was proposed to help with 
the development of new biotransformation processes on a large scale 
(kreis et al., 1992; see Growth of cell cultures in biorectors). 
Chasing enzymes of SNAP formation in plant cell cultures
To characterize enzymes and genes of a metabolic pathway the 
target enzyme needs to be purified, the protein sequenced and the 
appropriate nucleotide primers synthesized. This classical approach 
benefitted from some of the characteristics of plant cell cultures which 
can be cultivated under standardized conditions and manipulated in 
a multitude of ways. Protein extraction and purification of SNAP 
forming enzymes, which may occur in low concentrations only, 
turned out to be very straightforward and efficient (zenk, 1991). For 
example, ajmalicine was the first alkaloid whose biosynthesis was 
elucidated at the enzyme level using Catharanthus roseus (L.) G. 
Don cell suspension cultures (zenk, 1980). Much of the biosynthetic 
pathway leading to morphinane alkaloids was investigated using 
plant cell cultures (HaGel and FaccHini, 2013). Others and we 
isolated the enzymes involved in cardenolide biotransformation 
(kreis et al., 1998; see Biotransformation of SNAPs by plant 
cell cultures) and also investigated early steps of the cardenolide 
pathway. For instance, we isolated the Δ5-3β-hydroxysteroid de- 
hydrogenase (Dl3βHSD) from D. lanata tissues (seidel et al., 
1990). This enzyme catalyzes the formation of pregnenolone from 
progesterone. A more recent discovery is that Dl3βHSD, unlike other 
known mammalian enzymes, only has oxido-reductase activity but 
not Δ5-Δ4-ketosteroid-isomerase activity (meitinGer et al., 2016). 
Progesterone is further metabolized to 5β-pregnane-3,20-dione by 
the progesterone 5β-reductase (Gärtner et al., 1994) which was 
proposed to be the first regulatory ’key‘ enzyme in the 5β-cardenolide 
pathway. However, later it was shown that the enzyme was active 
and the respective gene expressed in suspension-cultured cells (not 
capable of producing cardenolides) and cardenolide-free tissues of 
D. lanata (ernst et al., 2010).
Enzymes at the start of a biosynthetic pathway are sometimes 
described as ‘key’ enzymes, but they are not necessarily rate-
limiting for production. The bottleneck(s) often occur further 
down the pathway. Rate-limiting or pathway-pivotal enzymes do 
not necessarily have to catalyze spectacular reactions but may 
instead only adorn scaffolds with small structural elements. This 
was nicely demonstrated in berberine-producing Thalictrum cell 
cultures. Zenk’s group and later Kutchan and co-workers (Frenzel 
and zenk, 1990; Frick and kutcHan, 1999) tried to ascertain why 
some cell culture strains were producing berberine-type alkaloids 
while others failed. They found that most of the enzymes necessary 
for the formation of protoberberines were present in non-producing 
cells but the full set of all four methyltransferases involved in 
protoberberine biosynthesis was only expressed in producing cells. 
Methyl groups attached to a scaffold by S-adenosyl-L-methionine-
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dependent methyltransferases can decide the destiny of a precursor. 
The precursor might not be funneled into the target pathway if the 
substitution pattern facilitates inappropriate condensation reactions 
due to the lack of protecting groups. Meinhart Zenk once stated 
that “the development of plant cell cultures for the study of the 
biosynthesis of secondary metabolites in the 1970s revolutionized 
the field. It became possible to identify, characterize and ultimately, 
in specific cases, to purify the biocatalysts involved in individual 
transformations. The precise knowledge of the biosynthetic pathways 
provided by the identification of these enzymes, of the stereo- and 
substrate-specificity of the reactions they catalyze and of the 
sequence of these reactions in situ opened new fields for study in 
plant sciences” (zenk, 1991) and indeed, for more than 30 years plant 
cell cultures have become a central tool to study SNAP formation.
It turned out that SNAP formation appears to utilize multidimensio- 
nal grids rather than linear pathways and that various factors can 
control the flux through a biosynthetic grid. These factors are: (1) 
enzyme amount/activity, (2) metabolite inhibition/stimulation, (3) 
pathway competition, (4) co-factor availability, and (5) compart-
mentalization (VerPoorte et al., 2000). Potential flux limitations 
can be investigated by feeding different precursors to cultured plant 
tissues or cells. The question arose of how specialized SNAP me-
tabolism actually is because the multitude of metabolites found in 
living organisms does not correspond with the small number of 
metabolic genes identified in the various genome studies (scHWaB, 
2003). Convergent, parallel, and divergent evolution can be seen in 
metabolic processes (PicHerskY and GanG, 2000; delGoda and 
murraY, 2017). Gene duplication (oHno, 1970) and divergence to 
more specialized enzymes may be important for SNAP formation 
(oBer, 2005). However, enzymes with a relaxed substrate specificity 
increase the possibility of producing a greater number of new chemi-
cals (WenG and noel, 2012; kreis and munkert, 2019). Enzymes 
may compete for common intermediates. A particular enzyme may 
catalyze a series of parallel reactions involving structurally related 
substrates. There are still metabolic uncertainties in every step of a 
given pathway or in a metabolic grid. The flux to a certain compound 
is predominantly decided by grid architecture. At enzymatic level 
only a few pathways/grids have been studied extensively enough to 
allow for serious pathway engineering (see Outlook). In most cases 
SNAP pathways are still far from being elucidated. As an example 
the biosynthesis of tropic acid and the ester alkaloid formation in 
scopolamine biosynthesis has been the subject of continued discus-
sion and remains an unresolved issue (Qiu et al., 2018).
Eventually SNAP formation research slipped into the genomic and 
post-genomic area. Screening of cDNA or genomic libraries and 
the use of PCR approaches made it possible to identify, isolate and 
clone genes involved in SNAP formation. It became feasible to ex-
press them heterologously in microorganisms with the aim to ob-
tain enough protein for characterization and structure elucidation. 
We also contributed to this field by elucidating the crystal structures 
of two progesterone 5β-reductases (eGerer-sieBer et al., 2006; 
scHmidt et al., 2018). During this phase plant cell cultures became 
nearly obsolete. This is underlined by the fact that about 10 years 
ago the DSMZ (German Collection of Microorganisms and Cell 
Cultures) maintained more than 700 different plant cell lines from 
more than 80 different plant families (kreis, 2007). In April 2019, 
41 plant cell lines were still provided as growing or cryopreserved 
cultures (DSZM, 2019a) but now (DSMZ, 2019b) the catalogue of 
strains does not offer plant cell cultures any longer. 
Either way plant cell cultures with their limited potential and 
complexity turned out to be a good system for metabolome studies. 
The metabolome is defined as the final downstream product of the 
genome and consists of all metabolites in a cell, tissue or organism. 
A SNAP metabolome may be defined as a part of the metabolome 
related to a specific group of SNAPs. The ‘taxane metabolome’ of a 
Taxus cell culture will hence comprise all taxanes, including taxa-
4,11-diene, formed by the initial action of a diterpene cyclase from 
geranyl-geranyl diphosphate and the highly complex paclitaxel that 
may be regarded as the end product of the taxane pathway. Over 
400 taxanes described so far are represented in this constrained 
metabolome (croteau and ketcHum, 2006) but most of them are 
not part of the actual paclitaxel biosynthetic pathway(s). Taxol bio- 
synthesis requires 19 enzymatic steps, but so far only 15 enzymes have 
been characterized (mcelroY and JenneWein, 2018). It involves 
eight oxidation steps, two CoA esterifications, N-benzoylation, five 
acetyl/aroyl transferase steps, a C4β,C20-epoxidation reaction, and 
a phenylalanine aminomutase step. Understanding the relationship 
among all intermediates in the metabolic grid may provide clues 
for metabolic engineering of plant cell cultures for increased taxol 
production. It has been stated that to increase taxol yields in Taxus 
cell cultures these „numerous and apparently diversionary taxoid bio- 
synthetic side-routes and dead-ends” have to be taken into account 
(croteau et al., 2006; see Commercialization of plant cell culture 
processes). 
Plant cell cultures have also been used to decipher multiple levels 
of cellular control of lignin deposition, composition, structure, and 
quantity. In this case, plant cell cultures have provided insights into 
the lignification processes that could not have been easily obtained 
by using whole plants (PesQuet et al., 2019).
Growth of plant cell cultures in bioreactors
Already in the 1960s John D. Bu’Lock (see Introduction) saw that 
biotechnology (at that time usually referred to as ‘fermentation 
technology’) would be the next big development to happen for 
the production of SNAPs. Large scale cultivation of plant cells in 
bioreactors was the obvious next step (kreis and reinHard, 1989; 
scraGG, 1995; SHARMA and SHAZAD, 2013; eiBl and eiBl, 2008). In 
the 1970s pneumatically agitated air-lift bioreactors were advertised 
and routinely used for the cultivation of plant cell aggregates that 
were assumed to be highly shear-sensitive (VerPoorte et al., 2002). 
Today many different designs and configurations of bioreactors for 
plant in vitro systems are available. The most common type of reactor 
for growing plant cells is the stirred-tank bioreactor, a mechanically 
agitated vessel. This type of reactor uses impellers for gas-liquid 
transfer and mixing. Though bioreactors are scalable, reproducing 
the physical environment (shear, mixing, gas transfer) is often 
difficult (e.g., scraGG, 1991). Big challenges in bioreactor design are 
the efficient illumination of phototrophic cell cultures (HuanG et al., 
2017) and the use of disposable bioreactors (eiBl and eiBl, 2008).
Some engineering aspects will have to be addressed before citing 
examples of processes developed (see Commercialization of plant 
cell culture processes). The ‘operating mode’ refers to how the nutri-
ent and product streams are supplied to or removed from a culture. 
When all nutrients are supplied from the beginning the operating 
mode is termed (1) batch culture. In a (2) fed-batch operation one 
or more nutrients are added to the bioreactor during cultivation, 
either in batches or continuously. Fed-batch mode is more suitable 
than standard batch cultivation if a nutrient or precursor is detrimen-
tal to the cells when supplied all at once. In (3) repeated fed-batch 
operation a substantial portion of the spent medium or the cell sus-
pension is withdrawn and replaced with fresh culture medium. (4) 
Two-stage batch mode involving a change of culture media is an op-
tion to allow for rapid growth in the first stage and product synthesis 
in a second stage. For example, a two-stage process for the produc-
tion of deacetyllanatoside C was designed and it was demonstrated, 
that this process can be run in a semi-continuous mode (kreis and 
reinHard, 1990). (5) Chemostat operation refers to a fermentation 
mode in which fresh medium is continuously fed to the bioreactor 
and a stream of cell suspension is continuously withdrawn for pro- 
 Natural products in plant cell cultures 221
duct harvest or metabolite analysis. In (6) perfusion operation fresh 
medium is added to the vessel continuously and only spent medium 
is withdrawn. For example, berberine production using Coptis ja-
ponica (Thunb.) Makino cells was improved by a factor of 6.5 when 
a continuous turbidostat set-up was used instead of the batch mode 
(matsuBara et al., 1989).
The perfusion reactor is also appropriate for immobilized producers. 
Immobilization is a technique which traps catalytically active cells 
or enzymes in a matrix that prevents them from entering the liquid 
phase. Plant cells immobilized in alginate or on porous glass beads 
have been used for the de novo biosynthesis of valuable SNAPs as 
well as for biotransformations (Yeoman, 1987; ramacHandra rao 
and raVisHankar, 2002; Brodelius, 2018). This issue will not be 
elaborated further here and the reader is referred to the respective 
reviews.
Commercialization of plant cell culture processes
During the dynamic 1980s I had the opportunity to visit Japan and 
some of the companies using plant cell cultures for the production 
of SNAPs already then. Mitsui Petrochemical Industries were about 
to establish processes for Vinca alkaloids, Rubia dyes, berberine, 
and shikonin, while Shiseido focused on an arbutin process using 
Catharanthus roseus (L.) G. Don cell cultures. Nitto Denko pro-
duced ginsenoside-rich biomass using Ginseng root cultures and 
Nippon Paint and Sanei Chemical ran their own plant cell culture 
projects. Optimization of berberine production from Coptis japonica 
(Thunb.) Makino cells resulted in a yield of 3.5 g/L after a scale 
up to 4 m3 (matsuBara et al., 1989). However, as recently pointed 
out by lanGe (2018) the introduction of plant tissue culture-derived 
fine chemicals to the market has been confined to few examples, in-
cluding the 1988 ‘one-hit wonder‘ shikonin (FuJita, 1988) and the 
‘showpiece‘ paclitaxel. Phyton Catalytic (now Phyton Biotech) began 
the scale-up of cell suspension cultures of Taxus chinensis (Miq.) 
de Laub. in the 1990s. After extensive studies, a large-scale culture 
process was developed where the addition of the ‘elicitor’ methyl 
jasmonate increased the productivity to 23.4 mg L-1 d-1 (ketcHum 
et al., 1999). A production volume of 75 m3 was established and in 
1995 the plant cell culture process was licensed to Bristol-Myers 
Squibb. Eventually several new tissue culture processes for cyto-
static taxanes emerged (cHoi et al., 2002; mcelroY and JenneWein, 
2018). 
It seems appropriate to comment on the profitability of plant cell 
culture at this point. First of all there has to be a sufficiently large 
market for the product. The most important parameter for possible 
commercialization of a cell culture process is its productivity. There 
are many different definitions of productivity. We defined it as the 
amount of product formed per volume and time. This figure is de-
pendent on growth and product formation rates. It takes into account 
unproductive phases and the time required for preparation and fol-
low-ups of a production run. It was estimated that the wholesale kilo 
price must be between 250 U.S. $ and 8,000 U.S. $ for any plant 
cell culture process with a production rate between 0.025 to 1.0 g of 
product L-1 d-1 (kreis, 1993). lanGe (2018) addressed various con- 
siderations for commercial targets like market value/volume, struc-
tural complexity/chemical synthesis, regulatory burden and consu- 
mer acceptance. He also provided a list of possible new targets, yet 
avoiding compounds that have ’fallen out of favor among clinicians‘, 
and focused on structurally complex and expensive SNAPs not easily 
accessible from the source plants.
Commercialization is hindered when there is a complex system of 
players. For example the anti-malaria drug artemisinin was regarded 
a good target compound and lots of efforts have been made to estab-
lish plant cell cultures to study artimisinin biosynthesis and to use 
them as a source for this valuable compound. So far commercializa-
tion of alternative processes, including a very promising yeast pro-
cess generating semi-synthetic artemisinin, has not been successful 
(PePloW, 2016). This illustrates the complexities of economic forces 
that affect the market for certain drugs. They also had an adverse 
impact on the metildigoxin process established in Ernst Reinhard’s 
group in Tübingen. The process was scaled-up to 5 m3 by Boehringer 
Mannheim (now Roche) and was regarded economically feasible. 
But the market for cardiac glycosides deteriorated and the high-yield 
plants obtained by selection breeding yielded enough digoxin to sa- 
tisfy the needs in the end.
But what happened to the shikonin process? The demand for shiko-
nin in 1988 was only around 150 kg per year with a market value of 
600,000 U.S. $. It turned out that production was not significantly 
cheaper than the extraction from Lithospermum erythrorhizon roots 
(lanGe, 2018) and hence the process abandoned.
Only recently, a bilberry cell culture process for the production of 
a polyphenol extract as a dietary supplement was announced by 
Diana Plant Sciences. They had already launched a cocoa product 
derived from Theobroma cacao L. suspension-cultured cells in 2013 
(lanGe, 2018). eiBl et al. (2018) gave an overview of plant cell cul-
ture extracts containing SNAPs such as polyphenols, vitamins, fatty 
acids, peptides for applications in the cosmetics and food industries. 
Teoside 10, an extract prepared from suspension-cultured Ajuga rep-
tans cells was the first plant cell culture extract approved as a food 
supplement ingredient in Europe. Only time will tell whether this 
gives notice of a renaissance of plant cell culture or of a sudden hype 
prone to extinction. 
Outlook
Although plant cell culture technologies have been around for de-
cades, it still seems to be difficult to commercialize plant cell cul-
ture processes, mainly due to the competition with already existing 
ways of manufacturing. But without any doubt, plant cell suspension 
cultures left their mark on various aspects of applied botany rela- 
ted to the elucidation of biochemical pathways and the production 
of SNAPs. In the genomic and post-genomic era plant cell cultures 
became less important tools to study biochemical pathways. New 
technologies emerged and homology search in genome and protein 
databases allowed for new strategies in pathway elucidation. Even if 
not all genes and enzymes of a given SNAP pathway are known the 
SNAP itself may be produced after merging genes from different 
organisms in an appropriate host. However, each step in a given path-
way is subject to uncertainties and there are many cases where the 
genetic engineering approach did not give the expected results. For 
example, the tryptophan decarboxylase gene introduced and consti-
tutively expressed in Catharanthus roseus (L.) G. Don cells resulted 
in an increase of tryptamine, but not in an increase of indole alkaloid 
production (Berlin and Fecker, 2000). In recent years, microorga- 
nisms were genetically engineered with a view to synthesize natural 
products usually derived from plants. Among these engineered path-
ways a lot of different target structures can be found, such as phenols, 
isoprenoids, alkaloids, and polyketides (siddiQui et al., 2012). For 
example, a Saccharomyces cerevisiae strain has been developed, 
which is capable of synthesizing hydrocortisone from a simple car-
bon source (dumas et al., 2006) and more recently, morphinanes 
have been produced in E. coli (nakaGaWa et al., 2016). Pathway 
engineering seems to be a promising approach for the production 
of a multitude SNAPS. Only recently, we have constructed a yeast 
expression plasmid containing a cardenolide biosynthetic module. It 
enables a yeast strain to produce 5β-pregnane-3β,21-diol-20-one, a 
central intermediate in 5β-cardenolide biosynthesis, starting from 
pregnenolone which we added to the culture medium. With this 
approach, five consecutive steps in cardenolide biosynthesis were 
realized in baker’s yeast (rieck et al., 2019). Two of the enzymes 
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used, namely Δ5-3β-hydroxysteroid dehydrogenase and progester-
one 5β-reductase were isolated for the first time in the 1980s from 
Digitalis cell and tissue cultures demonstrating again the impact of 
plant cell culture for basic research and applied botany.
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